Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Move Over, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season.
Canada won’t be ordering Novavax’s updated COVID-19 vaccine, cites low demand
The Public Health Agency of Canada says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine,
Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year
TORONTO - The Public Health Agency of Canada says it is not providing Novavax's COVID-19 vaccine this respiratory virus season, citing low demand.
15h
on MSN
Scientists develop mRNA vaccine that protects mice against intestinal C. difficile bacteria
A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...
2d
on MSN
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
CNET
6d
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
FierceBiotech
2d
Flexible mRNA vaccine protects mice from deadly C. diff infections, including recurring cases
The bacterium Clostridioides difficile is named “difficult” for a reason. Originally, it was hard to grow in the lab, and, ...
TMCnet
1d
MRNA Deadline: Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Moderna, Inc. (NASDAQ: MRNA) ...
Science News
3d
An mRNA vaccine protected mice against deadly intestinal C. difficile bacteria
An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.
5d
on MSN
Siloxane nanoparticles unlock precise organ targeting for mRNA therapy
Penn Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary ...
The Financial Express
13d
mRNA vaccines lead next-generation efforts to combat H5N1 amid global outbreaks: GlobalData
According to GlobalData, while the majority of the 22 vaccine candidates currently in development rely on traditional ...
3d
Should the federal government provide a non-mRNA vaccine for COVID-19 this respiratory virus season?
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...
Outsourcing-pharma
4d
Quotient Sciences expands with mRNA Focus at CPHI 2024
During the show, Quotient Sciences CEO Thierry Van Nieuwenhove will share insights on how the company is adapting to new FDA ...
1d
on MSN
Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Moderna
COVID-19
NASDAQ
CSL Limited
Nuvaxovid
Feedback